These three small-cap stocks are basically Goldilocks in stature, meaning their size is just right for delivering big portfolio gains. More
7 Biotechnology Stocks to Sell Now
The ratings of seven Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Avoid This Sector Until After Friday
I would caution against taking any major long or short positions in the financials right now. More
The 10 Best-Paid CEOs of 2012
The top 10 highest-paid CEOS of 2012 took home boatloads of money and got plenty more in perks. On the upside, all but one kept their companies in the black. More
Gold Looks Like a Buy Ahead of Next Week’s Earnings Onslaught
SPDR Gold Shares is setting up for a short-term bullish play. More
Solar Stocks Flare — Tuesday’s IP Market Recap
First Solar's 2013 guidance sent FSLR and the rest of the sector skyward Tuesday, and big gains by tech giants Microsoft and Intel propped up the Dow. More
